Clinical trial
A Randomised Evaluation of Molecular Guided Therapy for Diffuse Large B-cell Lymphoma With Bortezomib
NCT01324596 is registered in ClinicalTrials.gov with University Hospital Southampton NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised Evaluation of Molecular Guided Therapy for Diffuse Large B-cell Lymphoma With Bortezomib
- Lead sponsor
- University Hospital Southampton NHS Foundation Trust
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 30, 2011
- Completion date
- June 30, 2015
- Enrollment
- 1,132 (actual)
- Sites
- 109
Conditions
As the registry lists them; a condition with its own page is linked.